SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-20-004426
Filing Date
2020-06-11
Accepted
2020-06-11 16:18:05
Documents
2
Period of Report
2020-06-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4334
2 MICHAEL COLA POA 2019 michaelcolapoa2019.txt EX-24 2145
  Complete submission text file 0001562180-20-004426.txt   7794
Mailing Address 435 DEVON PARK BUILDING 800 WAYNE PA 19087-1945
Business Address
COLA MICHAEL F (Reporting) CIK: 0001188940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 20957382

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations